Clinical profile and in-hospital outcomes of COVID-19 patients: Findings from secondary data analysis.
COVID-19
Comorbidity
first wave
medical records
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
22
09
2021
revised:
19
12
2021
accepted:
22
12
2021
entrez:
19
9
2022
pubmed:
20
9
2022
medline:
20
9
2022
Statut:
ppublish
Résumé
Uttarakhand, a hilly state in north India, reported the first coronavirus disease (COVID) case on 15 March 2020. Since then, the case numbers rose multiple folds. As Uttarakhand has been on a 'war-footing' amidst the recent second wave and is gearing up to fight against the third wave, the present study aims to uncover baseline clinical profile and in-hospital outcomes of COVID patients in Dehradun district (Uttarakhand) during the first wave. A record-based descriptive analysis was carried out for 671 COVID patients admitted to a private dedicated COVID hospital in Dehradun district between August 2020 and February 2021. Data was collected from medical records on a standardized abstraction form. Data was entered and analyzed using Statistical Package for Social Sciences (SPSS) version 20. The present study showed most admitted COVID patients were males, aged 40 years and above, moderately ill, had co-morbidities with about one-fourth lately succumbed to death. The proportions of deaths, moderate-to-severe and severe category of illness were invariably high for those with co-morbidities irrespective of the gender. Females, age <60 years, and absence of co-morbidities had overall high mean survival estimates from COVID. Females, younger age group, and absence of co-morbidities are more likely to survive from COVID than males, older age groups, and those with co-morbidities.
Sections du résumé
Background
UNASSIGNED
Uttarakhand, a hilly state in north India, reported the first coronavirus disease (COVID) case on 15 March 2020. Since then, the case numbers rose multiple folds. As Uttarakhand has been on a 'war-footing' amidst the recent second wave and is gearing up to fight against the third wave, the present study aims to uncover baseline clinical profile and in-hospital outcomes of COVID patients in Dehradun district (Uttarakhand) during the first wave.
Methods
UNASSIGNED
A record-based descriptive analysis was carried out for 671 COVID patients admitted to a private dedicated COVID hospital in Dehradun district between August 2020 and February 2021. Data was collected from medical records on a standardized abstraction form. Data was entered and analyzed using Statistical Package for Social Sciences (SPSS) version 20.
Results
UNASSIGNED
The present study showed most admitted COVID patients were males, aged 40 years and above, moderately ill, had co-morbidities with about one-fourth lately succumbed to death. The proportions of deaths, moderate-to-severe and severe category of illness were invariably high for those with co-morbidities irrespective of the gender. Females, age <60 years, and absence of co-morbidities had overall high mean survival estimates from COVID.
Conclusion
UNASSIGNED
Females, younger age group, and absence of co-morbidities are more likely to survive from COVID than males, older age groups, and those with co-morbidities.
Identifiants
pubmed: 36119348
doi: 10.4103/jfmpc.jfmpc_1900_21
pii: JFMPC-11-2545
pmc: PMC9480643
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2545-2551Informations de copyright
Copyright: © 2022 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
BMC Geriatr. 2020 Oct 8;20(1):395
pubmed: 33032534
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
J Assoc Physicians India. 2020 May;68(5):13-17
pubmed: 32610859
Int J Infect Dis. 2016 Aug;49:129-33
pubmed: 27352628
Indian J Med Res. 2020 Jul & Aug;152(1 & 2):61-69
pubmed: 32773414
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J Diabetes Metab Disord. 2021 Mar 31;20(1):939-950
pubmed: 33821206
Clin Rev Allergy Immunol. 2019 Jun;56(3):308-321
pubmed: 28963611
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
BMC Public Health. 2020 Oct 27;20(1):1616
pubmed: 33109136
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
J Immunol. 2017 May 15;198(10):4046-4053
pubmed: 28373583
Invest Radiol. 2020 Jun;55(6):327-331
pubmed: 32118615
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347201
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Int J Infect Dis. 2022 Jan;114:202-209
pubmed: 34781004